Revive Therapeutics Submits Cannabinoid Delivery Technology …

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, today announced that it has submitted an abstract for the XXIX International Conference on Polyphenols and the 9th Tannin Conference (“ICP + TC 2018”) that contains results from its research project with the University of Wisconsin-Madison for the development of a novel cannabinoid delivery technology.

“We are pleased to submit the results demonstrating a unique cannabinoid delivery technology for presentation at this year’s ICP + TC 2018 more at